益生菌降低终末期肾脏疾病蛋白结合毒素的研究进展
<正>随着社会老龄化及糖尿病、高血压等慢性疾病发病率升高,全球慢性肾脏病（chronic kidney disease,CKD）患病人数逐年增加<sup>[1]</sup>。根据最新流行病学调查显示,我国成年人群中CKD的患病率为10.8%,据此估计我国现有成年CKD患者1.2亿<sup>[2]</sup>。大量CKD患者随着病程发展进展为终末期肾病（end stage renal disease,ESRD）,预后较差。欧洲肾脏协会及欧洲透析移植协会（ERA-EDTA）统计数据显示,65<sup>7</sup>4岁ESRD人群预期寿命较正常人群缩短50%<sup>[3]</sup>。ESRD已...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Chinês |
| Baskı/Yayın Bilgisi: |
Editorial Department of Journal of Clinical Nephrology
2015-01-01
|
| Seri Bilgileri: | Linchuang shenzangbing zazhi |
| Online Erişim: | http://www.lcszb.com/thesisDetails?columnId=57919978&Fpath=home&index=0 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|